Interferon-α After DLI for the Prevention of Relapse
NCT02568241
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Leukemia
Interventions
OTHER:
Interferon Alfa-2b
Sponsor
Peking University People's Hospital